DAVID WOODBURY: Open Payments
NPI 1598136368 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$129 in 6 payments from 5 companies in 2025. Trend: 2023 $39 · 2024 $138 · 2025 $129
Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $57 |
| Lilly USA, LLC | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: Kerecis SurgiClose, TALTZ, TREMFYA, Sotyktu, COSENTYX.
Industry payments across ID — which companies pay providers there.
